Brad Loncar is a biotechnology industry investor and CEO of Loncar Investments. He is the creator of two Nasdaq-listed biotech focused exchange-traded funds. Brad previously worked in the financial services industry at Franklin Templeton Investments where he was a member of the Management Training Program, and was appointed to serve in a Senior Advisor role at the U.S. Department of the Treasury. He currently writes biotechnology commentary at www.LoncarBlog.com, Nasdaq.com, and contributes opinion pieces to Endpoints News.
Explore BIO
BIO DOUBLE HELIX SPONSORS





BIO HELIX SPONSORS





1201 New York NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2022 All Rights Reserved